Companies

Rezolute, Inc. (RZLT) SEC filings

CIK 0001509261 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in NV · fiscal year ends 06/30

Annual financials (from the company's own XBRL in its 10-K filings)

FY2026FY2025FY2024FY2023
Net income (USD)-51.8 M-41.1 M
Diluted EPS (USD/shares)-0.75-1.33-1.01

Latest filings

FiledFormDescriptionPeriod
2026-10-148-KFORM 8-K items 7.01,9.012026-10-14
2026-10-07PRE 14APRE 14A2026-12-02
2026-10-058-KFORM 8-K items 7.01,9.012026-10-05
2026-09-2410-K10-K2026-06-30
2026-09-248-KFORM 8-K items 2.02,9.012026-09-24
2026-09-034FORM 42026-09-02
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-12SCHEDULE 13GSCHEDULE 13G
2026-07-074FORM 42026-07-02
2026-07-074FORM 42026-07-02
2026-07-074FORM 42026-07-02
2026-06-028-KFORM 8-K items 7.01,9.012026-06-02
2026-05-15SCHEDULE 13GSCHEDULE 13G
2026-05-1210-Q10-Q2026-03-31
2026-05-128-KFORM 8-K items 2.02,9.012026-05-12
2026-05-11SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-048-KFORM 8-K items 7.01,9.012026-05-01
2026-03-314FORM 42026-03-30
2026-03-26SCHEDULE 13G/ASCHEDULE 13G/A
2026-03-248-KFORM 8-K items 7.01,9.012026-03-24
2026-03-044FORM 42026-03-02
2026-03-044FORM 42026-03-02
2026-03-044FORM 42026-03-02
2026-02-13SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 8-K 182, 4 172, 10-Q 45, 3 31, 424B3 31, EFFECT 29, CORRESP 25, UPLOAD 25. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=RZLT (0.002 USD), /gw/filings/filings?ticker=RZLT&form=8-K, /gw/filings/facts?ticker=RZLT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange